Sponsor Pipeline

JHM BioPharma (Tonghua) Co. , Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT06937944
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to…		 date change Primary completion pushed: 2025-12 -> 2026-02-09
2026-08-06 NCT07242300
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the…		 Recruitment opened
2026-08-06 NCT07242300
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the…		 Trial sites expanded: 2 -> 12 locations
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06937944 Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to… Moderate to Severe Glabellar Lines Recruiting
NCT07242300 Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the… Upper Limb Spasticity (ULS) Recruiting
Get alerts when JHM BioPharma (Tonghua) Co. , Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free